Cargando…
S100B, Actor and Biomarker of Mild Traumatic Brain Injury
Mild traumatic brain injury (mTBI) accounts for approximately 80% of all TBI cases and is a growing source of morbidity and mortality worldwide. To improve the management of children and adults with mTBI, a series of candidate biomarkers have been investigated in recent years. In this context, the m...
Autores principales: | Oris, Charlotte, Kahouadji, Samy, Durif, Julie, Bouvier, Damien, Sapin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095287/ https://www.ncbi.nlm.nih.gov/pubmed/37047574 http://dx.doi.org/10.3390/ijms24076602 |
Ejemplares similares
-
S100B Blood Level Determination for Early Management of Ski-Related Mild Traumatic Brain Injury: A Pilot Study
por: Kahouadji, Samy, et al.
Publicado: (2020) -
Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial
por: Bouvier, Damien, et al.
Publicado: (2019) -
Ionized Magnesium: Interpretation and Interest in Atrial Fibrillation
por: Bouillon-Minois, Jean-Baptiste, et al.
Publicado: (2023) -
Method validation of a set of 12 GEM® Premier™ 4000 blood gas analyzers for point-of-care testing in a university teaching hospital
por: Oris, Charlotte, et al.
Publicado: (2017) -
S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury
por: Calcagnile, Olga, et al.
Publicado: (2013)